메뉴 건너뛰기
Archives of Pathology and Laboratory Medicine
Volumn 134, Issue 2, 2010, Pages 163-
In Reply
Author keywords

[No Author keywords available]
Indexed keywords

EID: 76449084145     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Letter
Times cited : (1)
References (6)
  • 1
    • 33847147313 scopus 로고    scopus 로고
    • American society of clinical oncology/college of American pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    • Wolf AC, Hammond EH, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists Guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol. 2007;25(1):118-145.
    • (2007) J Clin Oncol. , vol.25 , Issue.1 , pp. 118-145
    • Wolf, A.C.1    Hammond, E.H.2    Schwartz, J.N.3
  • 2
    • 33846568336 scopus 로고    scopus 로고
    • American society of clinical oncology/college of American pathologists guideline recommendation for human epidermal growth factor receptor 2 testing in breast cancer
    • Wolf AC, Hammond EH, Schwartz JN, et al. American Society of Clinical Oncology/College of American Pathologists Guideline recommendation for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 2007;131(1):18-43.
    • (2007) Arch Pathol Lab Med , vol.131 , Issue.1 , pp. 18-43
    • Wolf, A.C.1    Hammond, E.H.2    Schwartz, J.N.3
  • 3
    • 65649135081 scopus 로고    scopus 로고
    • Implementation of American society of clinical oncology/ college of American pathologists HER2 guideline recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases
    • Middleton LP, Price KM, Puig P, et al. Implementation of American Society of Clinical Oncology/ College of American Pathologists HER2 guideline recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases. Arch Pathol Lab Med. 2009;133(5):775-780.
    • (2009) Arch Pathol Lab Med. , vol.133 , Issue.5 , pp. 775-780
    • Middleton, L.P.1    Price, K.M.2    Puig, P.3
  • 4
    • 23044475881 scopus 로고    scopus 로고
    • Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining
    • Lewis JT, Ketterling RP, Halling KC, et al. Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining. Am. J Clin Pathol. 2005;124(2):273-281.
    • (2005) Am J Clin Pathol. , vol.124 , Issue.2 , pp. 273-281
    • Lewis, J.T.1    Ketterling, R.P.2    Halling, K.C.3
  • 5
    • 64849095162 scopus 로고    scopus 로고
    • Genetic heterogeneity in HER2 testing in breast cancer: Panel summary and guidelines
    • Vance GH, Barry TS, Bloom KJ, et al. Genetic heterogeneity in HER2 testing in breast cancer: panel summary and guidelines. Arch Pathol Lab Med. 2009;133(4):611-612.
    • (2009) Arch Pathol Lab Med. , vol.133 , Issue.4 , pp. 611-612
    • Vance, G.H.1    Barry, T.S.2    Bloom, K.J.3
  • 6
    • 73549121892 scopus 로고    scopus 로고
    • Benefit of adjuvant trastuzumab in breast cancer patients with focal HER2 amplified colonies: Data from N9831 Intergroup Adjuvant Trial [abstract]
    • Sukov WR, Miller DV, Duek AC, et al. Benefit of adjuvant trastuzumab in breast cancer patients with focal HER2 amplified colonies: data from N9831 Intergroup Adjuvant Trial [abstract]. J Clin Oncol. 2009;27:15s(suppl):520.
    • (2009) J Clin Oncol. , vol.27 , Issue.15 A AND SUPPL. , pp. 520
    • Sukov, W.R.1    Miller, D.V.2    Duek, A.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.